Subsurface and critical infrastructure muography for 3D/4D mapping to transform real-time industrial exploration and monitoring.
Biotech focused on the development of regenerative cardiac therapies to restore tissue damaged after a heart attack.
New immunotherapy for cancer treatment.
Develops an intelligent intra-articular prosthesis to replace the anterior cruciate ligament (ACL), accelerating recovery and enabling real-time postoperative monitoring.
Company focused on developing genetic herbicides to selectively and sustainably control herbicide-resistant weeds.
Develops next-generation drugs based on targeted protein degradation with high selectivity for target and tissue.
New generation of mechanical heart valve prosthesis.
Cryopreservation for reproductive medicine without nitrogen refills, in a safe and traceable way, ensuring respect for the patient’s decision.
Development of new therapies for obesity and type II diabetes.
Screening for diagnosis and follow-up of cancer patients.
Animal protein grown in bioreactors.
Smart intraocular MEMS microvalve for the prevention of blindness in patients with refractory Glaucoma.
Develops innovative biotechnological solutions to decentralize and universalize access to rapid and accurate diagnostics.
Company focused on developing bactericides to combat infections caused by antibiotic-resistant microorganisms.
Lab as a Service aimed at accelerating the discovery of new drugs.
New therapy for the treatment of fibrotic diseases such as Scleroderma, Hepatic fibrosis & NASH, and cancer.
Develops innovative drugs based on synthetic single-stranded oligonucleotides that modulate the immune system and regenerate tissues, focusing on treating chronic inflammatory diseases.
Robot as a Service (RAAS) platform capable of instantly doubling parking capacity in cities.
Teramot introduces a new concept in software infrastructure, leveraging artificial intelligence, to help companies organize and access their information instantly.
Early diagnosis of Alzheimer’s and other dementias.